Whether E2F1 and E2F7 competitively bind to the MYBL2 promoter and whether disrupting the balance between the two opposing E2F transcriptional activities influences the transcription of MYBL2 and consequently the development of GC is worth exploring further. The gene discussed is MYBL2; the disease is gastric cancer.